Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia

Completed · Phase 2

Conditions studied: Leukemia

In brief

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving combination chemotherapy works in treating patients with acute promyelocytic leukemia.

Key facts

Study ID

NCT00276601

Run by

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Starts

2004-10-01

Expected to finish

2013-06-01

Last updated by the study team

2014-04-17

Who can join

Age: 5 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Comprehensive Cancer Center at University of Alabama at Birmingham — Birmingham, Alabama, United States
• University of Florida Shands Cancer Center — Gainesville, Florida, United States
• Blood and Marrow Transplant Group of Georgia — Atlanta, Georgia, United States
• Greenebaum Cancer Center at University of Maryland Medical Center — Baltimore, Maryland, United States
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
• UNMC Eppley Cancer Center at the University of Nebraska Medical Center — Omaha, Nebraska, United States
• Hillman Cancer Center at University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.